LENZ vs RTX · rev $7.4M vs P/E 36, rev $46.78B
LENZ Therapeutics Inc (LENZ) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
LENZ currently screens at market cap $223.6M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the LENZ and RTX stock pages for the full models.
Not investment advice.